Newsroom
GADx experiences at ADLM – Innovations & Collaborations!
Considering ADLM but not sure if it’s right for you? Find out if it should be on your radar as we share our experiences. The Association for Diagnostic Laboratory Medicine (ADLM) conference is the go-to…
New Study Investigates Biomarkers for Kidney Health Assessment
Mologic (D/B/A Global Access Diagnostics: GADx) is pleased to announce its collaboration on an important study with Johns Hopkins University, recently published in Scientific Reports. The research, titled “The Development of Lateral Flow Devices for…
REASSURED: A framework for developing diagnostics for resource limited settings
For global health, the need for effective diagnostics in resource-limited settings has never been more pressing. At the recent Point-of-Care Testing (POCT) Meeting in Leipzig, 130 industry leaders and innovators gathered to discuss the latest…
Reflections from the International Pandemic Sciences Conference 2024
The historic city of Oxford recently played host to the International Pandemic Sciences Conference 2024, an event that drew over 450 delegates from around the world. Held at the prestigious University of Oxford, the conference…
GADx Contributes to TB Diagnostic Advancements
GADx is pleased to announce its significant contribution to a groundbreaking study published in PLoS One. The research, titled “Performance of Novel Antibodies for Lipoarabinomannan to Develop Diagnostic Tests for Mycobacterium tuberculosis,” showcases the collaborative…
Global Access Diagnostics (GADx) selected as member of ARPA-H Investor Catalyst Hub spoke network
Global Access Diagnostics (GADx) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H). …
Botswana, a major animal health player on the African Continent
In 2023, Botswana hosted the 25th World Organization for Animal Health (WOAH) Regional Commission for Africa conference in Gaborone. At the opening of the event, the Botswana Institute for Technology Research and Innovation (BITRI) presented…
GHLabs x GADx: PoC innovation in molecular diagnostics
The sensitivity of molecular testing is now being revolutionised for point-of-care (PoC) usage. PCR, known for its high sensitivity and specificity, is the gold standard in diagnosing many infectious diseases. However, its availability has been…
New CEO at GADx, Dr Mark Street-Docherty
It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty. Mark brings with him enormous experience of leading…
GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…